Intervention

Neoadjuvant endocrine therapy

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting2

Common conditions9

Lead sponsors shown3

Clinical trials

3 shown

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast CancerNCT07483307 · 2026-03-13

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)NCT06806930 · 2024-10-01

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer PatientsNCT02532400 · 2016-03-01

Common conditions

Breast Cancer2 Breast Cancer Stage I1 Breast Cancer Stage II1 Breast Cancer Stage III1 Carcinoma, Breast1 ER+ Breast Cancer1 HER2 Negative Breast Carcinoma1 HER2-negative Breast Cancer1 Lobular Breast Carcinoma1

Leading sponsors

George Washington University1 Memorial Sloan Kettering Cancer Center1 Ruijin Hospital1

Trial status mix

RECRUITING2

TERMINATED1

Phase mix

PHASE22

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.